Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

30 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Inhibition of JNK reduces G2/M transit independent of p53, leading to endoreduplication, decreased proliferation, and apoptosis in breast cancer cells.
Mingo-Sion AM, Marietta PM, Koller E, Wolf DM, Van Den Berg CL. Mingo-Sion AM, et al. Among authors: van den berg cl. Oncogene. 2004 Jan 15;23(2):596-604. doi: 10.1038/sj.onc.1207147. Oncogene. 2004. PMID: 14724588
c-Jun N-terminal kinase 2 prevents luminal cell commitment in normal mammary glands and tumors by inhibiting p53/Notch1 and breast cancer gene 1 expression.
Cantrell MA, Ebelt ND, Pfefferle AD, Perou CM, Van Den Berg CL. Cantrell MA, et al. Among authors: van den berg cl. Oncotarget. 2015 May 20;6(14):11863-81. doi: 10.18632/oncotarget.3787. Oncotarget. 2015. PMID: 25970777 Free PMC article.
Stress and IGF-I differentially control cell fate through mammalian target of rapamycin (mTOR) and retinoblastoma protein (pRB).
Popowski M, Ferguson HA, Sion AM, Koller E, Knudsen E, Van Den Berg CL. Popowski M, et al. Among authors: van den berg cl. J Biol Chem. 2008 Oct 17;283(42):28265-73. doi: 10.1074/jbc.M805724200. Epub 2008 Aug 11. J Biol Chem. 2008. PMID: 18697743 Free PMC article.
PKCdelta and mTOR interact to regulate stress and IGF-I induced IRS-1 Ser312 phosphorylation in breast cancer cells.
Mingo-Sion AM, Ferguson HA, Koller E, Reyland ME, Van Den Berg CL. Mingo-Sion AM, et al. Among authors: van den berg cl. Breast Cancer Res Treat. 2005 Jun;91(3):259-69. doi: 10.1007/s10549-005-0669-0. Breast Cancer Res Treat. 2005. PMID: 15952059
Igf-I influence on breast cancer cell survival.
Van Den Berg CL. Van Den Berg CL. Breast Dis. 2003;17:49-59. doi: 10.3233/bd-2003-17106. Breast Dis. 2003. PMID: 15687677
An inhibitory function for JNK in the regulation of IGF-I signaling in breast cancer.
Mamay CL, Mingo-Sion AM, Wolf DM, Molina MD, Van Den Berg CL. Mamay CL, et al. Among authors: van den berg cl. Oncogene. 2003 Jan 30;22(4):602-14. doi: 10.1038/sj.onc.1206186. Oncogene. 2003. PMID: 12555073
UV-induced apoptosis is mediated independent of caspase-9 in MCF-7 cells: a model for cytochrome c resistance.
Ferguson HA, Marietta PM, Van Den Berg CL. Ferguson HA, et al. Among authors: van den berg cl. J Biol Chem. 2003 Nov 14;278(46):45793-800. doi: 10.1074/jbc.M307979200. Epub 2003 Sep 3. J Biol Chem. 2003. PMID: 12954616
Jnk2 effects on tumor development, genetic instability and replicative stress in an oncogene-driven mouse mammary tumor model.
Chen P, O'Neal JF, Ebelt ND, Cantrell MA, Mitra S, Nasrazadani A, Vandenbroek TL, Heasley LE, Van Den Berg CL. Chen P, et al. Among authors: van den berg cl. PLoS One. 2010 May 3;5(5):e10443. doi: 10.1371/journal.pone.0010443. PLoS One. 2010. PMID: 20454618 Free PMC article.
Development of JNK2-selective peptide inhibitors that inhibit breast cancer cell migration.
Kaoud TS, Mitra S, Lee S, Taliaferro J, Cantrell M, Linse KD, Van Den Berg CL, Dalby KN. Kaoud TS, et al. Among authors: van den berg cl. ACS Chem Biol. 2011 Jun 17;6(6):658-66. doi: 10.1021/cb200017n. Epub 2011 Apr 5. ACS Chem Biol. 2011. PMID: 21438496 Free PMC article.
c-Jun N-terminal Kinase 2 Regulates Multiple Receptor Tyrosine Kinase Pathways in Mouse Mammary Tumor Growth and Metastasis.
Nasrazadani A, Van Den Berg CL. Nasrazadani A, et al. Among authors: van den berg cl. Genes Cancer. 2011 Jan;2(1):31-45. doi: 10.1177/1947601911400901. Genes Cancer. 2011. PMID: 21779479 Free PMC article.
30 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page